YPSOMED is a Swiss based developer and manufacturer of self-injection devices with nearly 40 years of experience and numerous high precision and high quality devices on the global market.
Ypsomed provides a complete range of technologies and services for reliable and user-friendly self-injection systems for injectables such as insulin, GLP-1, hGH and mAbs. Our customers are pharmaceutical and biotechnology companies worldwide that develop, manufacture and market medications for self-injection.